Heartcore's go ipo client, sbc medical group, begins trading on the nasdaq stock exchange

Company anticipates q3 2024 revenue to be between $19 million-$23 million and net profit to be between $4 million-$8 million company anticipates q3 2024 revenue to be between $19 million-$23 million and net profit to be between $4 million-$8 million
NDAQ Ratings Summary
NDAQ Quant Ranking